Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: A retrospective clinical study-Reference-Cited by-同舟云学术

Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: A retrospective clinical study

Published:2011-10 Issue:10 Volume:37 Page:876-882
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Sanpaolo P.,Barbieri V.,Genovesi D.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference29 articles.

1. Molecular profiling of breast cancer: clinical implications;Cleator;Br J Cancer,2004

2. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci U S A,2003

3. Breast cancer revisited DNA array-based gene expression profiling;Bertucci;Int J Cancer,2003

4. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999–2004;Parise;Breast J,2009

5. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy;Nguyen;J Clin Oncol,2008

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term locoregional recurrence in patients treated for breast cancer;Breast Cancer Research and Treatment;2023-09-14

2. Molecular Subtypes and Ki-67 index in Breast Carcinoma with Special Emphasis on Triple Negative Breast Cancer. A 3-year Study in a Tertiary Care Center;Indian Journal of Surgical Oncology;2023-05-30

3. Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study;World Journal of Surgical Oncology;2023-03-27

4. Neoadjuvant treatment and survival outcomes by pathologic complete response in HER2-negative early breast cancers;Future Oncology;2023-01

5. Geriatric Breast Cancer: Staging, Molecular Surrogates, and Treatment. A Review & Meta-analysis;Aging and disease;2023